Bharat Immunological Biological Corporation Ltd vs Veerhealth Care Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Bharat Immunological & Biological Corporation Ltd is ₹ 17.3 as of 06 May 15:30 . The P/E Ratio of Bharat Immunological & Biological Corporation Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Veerhealth Care Ltd changed from 13.8 on March 2021 to 61.2 on March 2025 . This represents a CAGR of 34.70% over 5 years The Market Cap of Bharat Immunological & Biological Corporation Ltd changed from ₹ 196.47 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe Market Cap of Veerhealth Care Ltd changed from ₹ 5.27 crore on March 2021 to ₹ 24.48 crore on March 2025 . This represents a CAGR of 35.96% over 5 years The revenue of Bharat Immunological & Biological Corporation Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Veerhealth Care Ltd for the Dec '25 is ₹ 6.97 crore as compare to the Sep '25 revenue of ₹ 4.21 crore. This represent the growth of 65.56% The ebitda of Bharat Immunological & Biological Corporation Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Veerhealth Care Ltd for the Dec '25 is ₹ 0.94 crore as compare to the Sep '25 ebitda of ₹ 0.76 crore. This represent the growth of 23.68% The net profit of Bharat Immunological & Biological Corporation Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Veerhealth Care Ltd changed from ₹ 0.12 crore to ₹ 0.4 crore over 7 quarters. This represents a CAGR of 98.97% The Dividend Payout of Bharat Immunological & Biological Corporation Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Veerhealth Care Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Bharat Immunological & Biological Corporation Ltd

The Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) is a Central Public Sector Unit, under the Department of Biotechnology, Ministry of Science and Technology.
BIBCOL was incorporated in 1989.
The Company is engaged in the manufacture of Oral Polio Vaccine (OPV) , Zinc Tablets and Diarehha management Kit and BIB Sweet Tablets. The company's manufacturing unit is located in Bulandshahr Dist., Uttar Pradesh.
BIBCL installed a plant of 100 mln units.
Commercial production of the OPV started from Jan'96. The company has received firm orders for supply of OPV from the Ministry of Health and Family Welfare, Government of India, for use in the national immunisation programme.

About Veerhealth Care Ltd

Veerhealth Care Limited was originally incorporated on 10 July, 1992 as Niyati Leasing Limited to start business in Investment and Finance.
The main objects of the Company in 1998 got changed and accordingly the name was changed from Niyati Leasing Limited to Niyati Industries Limited and from Niyati Industries Limited to Veerhealth Care Limited in May, 2013. Initially in 2010, the Company was engaged into dealing and trading of shares, securities, debentures, and other investments.
It wanted to start business in the field of infrastructure.
Later on, the Company through the Main Objects, diversify the business activities to Pharma sector in 2013.
Apart from Tablet, Syrup, Ointment, Powder, it also started manufacturing in the Oil, Shampoo, Ointment and Toothpaste Division in year 2015-16.

FAQs for the comparison of Bharat Immunological & Biological Corporation Ltd and Veerhealth Care Ltd

Which company has a larger market capitalization, Bharat Immunological & Biological Corporation Ltd or Veerhealth Care Ltd?

Market cap of Bharat Immunological & Biological Corporation Ltd is 74 Cr while Market cap of Veerhealth Care Ltd is 42 Cr

What are the key factors driving the stock performance of Bharat Immunological & Biological Corporation Ltd and Veerhealth Care Ltd?

The stock performance of Bharat Immunological & Biological Corporation Ltd and Veerhealth Care Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Bharat Immunological & Biological Corporation Ltd and Veerhealth Care Ltd?

As of May 6, 2026, the Bharat Immunological & Biological Corporation Ltd stock price is INR ₹17.3. On the other hand, Veerhealth Care Ltd stock price is INR ₹21.14.

How do dividend payouts of Bharat Immunological & Biological Corporation Ltd and Veerhealth Care Ltd compare?

To compare the dividend payouts of Bharat Immunological & Biological Corporation Ltd and Veerhealth Care Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.